Global Cancer Gene Testing Service Market Research Report 2023
This report aims to provide a comprehensive presentation of the global market for Cancer Gene Testing Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Gene Testing Service.
The Cancer Gene Testing Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Cancer Gene Testing Service market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Gene Testing Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Gene Testing Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Cancer Gene Testing Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Cancer Gene Testing Service market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Gene Testing Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
- Natera, Inc.
- Laboratory Corporation of America Holdings
- F. Hoffmann-La Roche Ltd
- Quest Diagnostics Incorporated
- CooperSurgical, Inc.
- Agilent Technologies, Inc.
- Thermo Fisher Scientific, Inc.
- Twist Bioscience
- Sophia Genetics
- Fulgent Genetic, Inc.
- Breast Cancer Risk Genetic Testing
- Stomach Cancer Risk Gene Testing
- Rectal Cancer Risk Genetic Testing
- Others
- Hospital
- Clinic
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Gene Testing Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Gene Testing Service Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Breast Cancer Risk Genetic Testing
1.2.3 Stomach Cancer Risk Gene Testing
1.2.4 Rectal Cancer Risk Genetic Testing
1.2.5 Others
1.3 Market by Application
1.3.1 Global Cancer Gene Testing Service Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Cancer Gene Testing Service Market Perspective (2018-2029)
2.2 Cancer Gene Testing Service Growth Trends by Region
2.2.1 Global Cancer Gene Testing Service Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cancer Gene Testing Service Historic Market Size by Region (2018-2023)
2.2.3 Cancer Gene Testing Service Forecasted Market Size by Region (2024-2029)
2.3 Cancer Gene Testing Service Market Dynamics
2.3.1 Cancer Gene Testing Service Industry Trends
2.3.2 Cancer Gene Testing Service Market Drivers
2.3.3 Cancer Gene Testing Service Market Challenges
2.3.4 Cancer Gene Testing Service Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Cancer Gene Testing Service Players by Revenue
3.1.1 Global Top Cancer Gene Testing Service Players by Revenue (2018-2023)
3.1.2 Global Cancer Gene Testing Service Revenue Market Share by Players (2018-2023)
3.2 Global Cancer Gene Testing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Gene Testing Service Revenue
3.4 Global Cancer Gene Testing Service Market Concentration Ratio
3.4.1 Global Cancer Gene Testing Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Gene Testing Service Revenue in 2022
3.5 Cancer Gene Testing Service Key Players Head office and Area Served
3.6 Key Players Cancer Gene Testing Service Product Solution and Service
3.7 Date of Enter into Cancer Gene Testing Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CANCER GENE TESTING SERVICE BREAKDOWN DATA BY TYPE
4.1 Global Cancer Gene Testing Service Historic Market Size by Type (2018-2023)
4.2 Global Cancer Gene Testing Service Forecasted Market Size by Type (2024-2029)
5 CANCER GENE TESTING SERVICE BREAKDOWN DATA BY APPLICATION
5.1 Global Cancer Gene Testing Service Historic Market Size by Application (2018-2023)
5.2 Global Cancer Gene Testing Service Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Cancer Gene Testing Service Market Size (2018-2029)
6.2 North America Cancer Gene Testing Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cancer Gene Testing Service Market Size by Country (2018-2023)
6.4 North America Cancer Gene Testing Service Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Cancer Gene Testing Service Market Size (2018-2029)
7.2 Europe Cancer Gene Testing Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cancer Gene Testing Service Market Size by Country (2018-2023)
7.4 Europe Cancer Gene Testing Service Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Cancer Gene Testing Service Market Size (2018-2029)
8.2 Asia-Pacific Cancer Gene Testing Service Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cancer Gene Testing Service Market Size by Region (2018-2023)
8.4 Asia-Pacific Cancer Gene Testing Service Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Cancer Gene Testing Service Market Size (2018-2029)
9.2 Latin America Cancer Gene Testing Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cancer Gene Testing Service Market Size by Country (2018-2023)
9.4 Latin America Cancer Gene Testing Service Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Cancer Gene Testing Service Market Size (2018-2029)
10.2 Middle East & Africa Cancer Gene Testing Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cancer Gene Testing Service Market Size by Country (2018-2023)
10.4 Middle East & Africa Cancer Gene Testing Service Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Natera, Inc.
11.1.1 Natera, Inc. Company Detail
11.1.2 Natera, Inc. Business Overview
11.1.3 Natera, Inc. Cancer Gene Testing Service Introduction
11.1.4 Natera, Inc. Revenue in Cancer Gene Testing Service Business (2018-2023)
11.1.5 Natera, Inc. Recent Development
11.2 Laboratory Corporation of America Holdings
11.2.1 Laboratory Corporation of America Holdings Company Detail
11.2.2 Laboratory Corporation of America Holdings Business Overview
11.2.3 Laboratory Corporation of America Holdings Cancer Gene Testing Service Introduction
11.2.4 Laboratory Corporation of America Holdings Revenue in Cancer Gene Testing Service Business (2018-2023)
11.2.5 Laboratory Corporation of America Holdings Recent Development
11.3 F. Hoffmann-La Roche Ltd
11.3.1 F. Hoffmann-La Roche Ltd Company Detail
11.3.2 F. Hoffmann-La Roche Ltd Business Overview
11.3.3 F. Hoffmann-La Roche Ltd Cancer Gene Testing Service Introduction
11.3.4 F. Hoffmann-La Roche Ltd Revenue in Cancer Gene Testing Service Business (2018-2023)
11.3.5 F. Hoffmann-La Roche Ltd Recent Development
11.4 Quest Diagnostics Incorporated
11.4.1 Quest Diagnostics Incorporated Company Detail
11.4.2 Quest Diagnostics Incorporated Business Overview
11.4.3 Quest Diagnostics Incorporated Cancer Gene Testing Service Introduction
11.4.4 Quest Diagnostics Incorporated Revenue in Cancer Gene Testing Service Business (2018-2023)
11.4.5 Quest Diagnostics Incorporated Recent Development
11.5 CooperSurgical, Inc.
11.5.1 CooperSurgical, Inc. Company Detail
11.5.2 CooperSurgical, Inc. Business Overview
11.5.3 CooperSurgical, Inc. Cancer Gene Testing Service Introduction
11.5.4 CooperSurgical, Inc. Revenue in Cancer Gene Testing Service Business (2018-2023)
11.5.5 CooperSurgical, Inc. Recent Development
11.6 Agilent Technologies, Inc.
11.6.1 Agilent Technologies, Inc. Company Detail
11.6.2 Agilent Technologies, Inc. Business Overview
11.6.3 Agilent Technologies, Inc. Cancer Gene Testing Service Introduction
11.6.4 Agilent Technologies, Inc. Revenue in Cancer Gene Testing Service Business (2018-2023)
11.6.5 Agilent Technologies, Inc. Recent Development
11.7 Thermo Fisher Scientific, Inc.
11.7.1 Thermo Fisher Scientific, Inc. Company Detail
11.7.2 Thermo Fisher Scientific, Inc. Business Overview
11.7.3 Thermo Fisher Scientific, Inc. Cancer Gene Testing Service Introduction
11.7.4 Thermo Fisher Scientific, Inc. Revenue in Cancer Gene Testing Service Business (2018-2023)
11.7.5 Thermo Fisher Scientific, Inc. Recent Development
11.8 Twist Bioscience
11.8.1 Twist Bioscience Company Detail
11.8.2 Twist Bioscience Business Overview
11.8.3 Twist Bioscience Cancer Gene Testing Service Introduction
11.8.4 Twist Bioscience Revenue in Cancer Gene Testing Service Business (2018-2023)
11.8.5 Twist Bioscience Recent Development
11.9 Sophia Genetics
11.9.1 Sophia Genetics Company Detail
11.9.2 Sophia Genetics Business Overview
11.9.3 Sophia Genetics Cancer Gene Testing Service Introduction
11.9.4 Sophia Genetics Revenue in Cancer Gene Testing Service Business (2018-2023)
11.9.5 Sophia Genetics Recent Development
11.10 Fulgent Genetic, Inc.
11.10.1 Fulgent Genetic, Inc. Company Detail
11.10.2 Fulgent Genetic, Inc. Business Overview
11.10.3 Fulgent Genetic, Inc. Cancer Gene Testing Service Introduction
11.10.4 Fulgent Genetic, Inc. Revenue in Cancer Gene Testing Service Business (2018-2023)
11.10.5 Fulgent Genetic, Inc. Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Gene Testing Service Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Breast Cancer Risk Genetic Testing
1.2.3 Stomach Cancer Risk Gene Testing
1.2.4 Rectal Cancer Risk Genetic Testing
1.2.5 Others
1.3 Market by Application
1.3.1 Global Cancer Gene Testing Service Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Cancer Gene Testing Service Market Perspective (2018-2029)
2.2 Cancer Gene Testing Service Growth Trends by Region
2.2.1 Global Cancer Gene Testing Service Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cancer Gene Testing Service Historic Market Size by Region (2018-2023)
2.2.3 Cancer Gene Testing Service Forecasted Market Size by Region (2024-2029)
2.3 Cancer Gene Testing Service Market Dynamics
2.3.1 Cancer Gene Testing Service Industry Trends
2.3.2 Cancer Gene Testing Service Market Drivers
2.3.3 Cancer Gene Testing Service Market Challenges
2.3.4 Cancer Gene Testing Service Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Cancer Gene Testing Service Players by Revenue
3.1.1 Global Top Cancer Gene Testing Service Players by Revenue (2018-2023)
3.1.2 Global Cancer Gene Testing Service Revenue Market Share by Players (2018-2023)
3.2 Global Cancer Gene Testing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Gene Testing Service Revenue
3.4 Global Cancer Gene Testing Service Market Concentration Ratio
3.4.1 Global Cancer Gene Testing Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Gene Testing Service Revenue in 2022
3.5 Cancer Gene Testing Service Key Players Head office and Area Served
3.6 Key Players Cancer Gene Testing Service Product Solution and Service
3.7 Date of Enter into Cancer Gene Testing Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CANCER GENE TESTING SERVICE BREAKDOWN DATA BY TYPE
4.1 Global Cancer Gene Testing Service Historic Market Size by Type (2018-2023)
4.2 Global Cancer Gene Testing Service Forecasted Market Size by Type (2024-2029)
5 CANCER GENE TESTING SERVICE BREAKDOWN DATA BY APPLICATION
5.1 Global Cancer Gene Testing Service Historic Market Size by Application (2018-2023)
5.2 Global Cancer Gene Testing Service Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Cancer Gene Testing Service Market Size (2018-2029)
6.2 North America Cancer Gene Testing Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cancer Gene Testing Service Market Size by Country (2018-2023)
6.4 North America Cancer Gene Testing Service Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Cancer Gene Testing Service Market Size (2018-2029)
7.2 Europe Cancer Gene Testing Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cancer Gene Testing Service Market Size by Country (2018-2023)
7.4 Europe Cancer Gene Testing Service Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Cancer Gene Testing Service Market Size (2018-2029)
8.2 Asia-Pacific Cancer Gene Testing Service Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cancer Gene Testing Service Market Size by Region (2018-2023)
8.4 Asia-Pacific Cancer Gene Testing Service Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Cancer Gene Testing Service Market Size (2018-2029)
9.2 Latin America Cancer Gene Testing Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cancer Gene Testing Service Market Size by Country (2018-2023)
9.4 Latin America Cancer Gene Testing Service Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Cancer Gene Testing Service Market Size (2018-2029)
10.2 Middle East & Africa Cancer Gene Testing Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cancer Gene Testing Service Market Size by Country (2018-2023)
10.4 Middle East & Africa Cancer Gene Testing Service Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Natera, Inc.
11.1.1 Natera, Inc. Company Detail
11.1.2 Natera, Inc. Business Overview
11.1.3 Natera, Inc. Cancer Gene Testing Service Introduction
11.1.4 Natera, Inc. Revenue in Cancer Gene Testing Service Business (2018-2023)
11.1.5 Natera, Inc. Recent Development
11.2 Laboratory Corporation of America Holdings
11.2.1 Laboratory Corporation of America Holdings Company Detail
11.2.2 Laboratory Corporation of America Holdings Business Overview
11.2.3 Laboratory Corporation of America Holdings Cancer Gene Testing Service Introduction
11.2.4 Laboratory Corporation of America Holdings Revenue in Cancer Gene Testing Service Business (2018-2023)
11.2.5 Laboratory Corporation of America Holdings Recent Development
11.3 F. Hoffmann-La Roche Ltd
11.3.1 F. Hoffmann-La Roche Ltd Company Detail
11.3.2 F. Hoffmann-La Roche Ltd Business Overview
11.3.3 F. Hoffmann-La Roche Ltd Cancer Gene Testing Service Introduction
11.3.4 F. Hoffmann-La Roche Ltd Revenue in Cancer Gene Testing Service Business (2018-2023)
11.3.5 F. Hoffmann-La Roche Ltd Recent Development
11.4 Quest Diagnostics Incorporated
11.4.1 Quest Diagnostics Incorporated Company Detail
11.4.2 Quest Diagnostics Incorporated Business Overview
11.4.3 Quest Diagnostics Incorporated Cancer Gene Testing Service Introduction
11.4.4 Quest Diagnostics Incorporated Revenue in Cancer Gene Testing Service Business (2018-2023)
11.4.5 Quest Diagnostics Incorporated Recent Development
11.5 CooperSurgical, Inc.
11.5.1 CooperSurgical, Inc. Company Detail
11.5.2 CooperSurgical, Inc. Business Overview
11.5.3 CooperSurgical, Inc. Cancer Gene Testing Service Introduction
11.5.4 CooperSurgical, Inc. Revenue in Cancer Gene Testing Service Business (2018-2023)
11.5.5 CooperSurgical, Inc. Recent Development
11.6 Agilent Technologies, Inc.
11.6.1 Agilent Technologies, Inc. Company Detail
11.6.2 Agilent Technologies, Inc. Business Overview
11.6.3 Agilent Technologies, Inc. Cancer Gene Testing Service Introduction
11.6.4 Agilent Technologies, Inc. Revenue in Cancer Gene Testing Service Business (2018-2023)
11.6.5 Agilent Technologies, Inc. Recent Development
11.7 Thermo Fisher Scientific, Inc.
11.7.1 Thermo Fisher Scientific, Inc. Company Detail
11.7.2 Thermo Fisher Scientific, Inc. Business Overview
11.7.3 Thermo Fisher Scientific, Inc. Cancer Gene Testing Service Introduction
11.7.4 Thermo Fisher Scientific, Inc. Revenue in Cancer Gene Testing Service Business (2018-2023)
11.7.5 Thermo Fisher Scientific, Inc. Recent Development
11.8 Twist Bioscience
11.8.1 Twist Bioscience Company Detail
11.8.2 Twist Bioscience Business Overview
11.8.3 Twist Bioscience Cancer Gene Testing Service Introduction
11.8.4 Twist Bioscience Revenue in Cancer Gene Testing Service Business (2018-2023)
11.8.5 Twist Bioscience Recent Development
11.9 Sophia Genetics
11.9.1 Sophia Genetics Company Detail
11.9.2 Sophia Genetics Business Overview
11.9.3 Sophia Genetics Cancer Gene Testing Service Introduction
11.9.4 Sophia Genetics Revenue in Cancer Gene Testing Service Business (2018-2023)
11.9.5 Sophia Genetics Recent Development
11.10 Fulgent Genetic, Inc.
11.10.1 Fulgent Genetic, Inc. Company Detail
11.10.2 Fulgent Genetic, Inc. Business Overview
11.10.3 Fulgent Genetic, Inc. Cancer Gene Testing Service Introduction
11.10.4 Fulgent Genetic, Inc. Revenue in Cancer Gene Testing Service Business (2018-2023)
11.10.5 Fulgent Genetic, Inc. Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Cancer Gene Testing Service Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Breast Cancer Risk Genetic Testing
Table 3. Key Players of Stomach Cancer Risk Gene Testing
Table 4. Key Players of Rectal Cancer Risk Genetic Testing
Table 5. Key Players of Others
Table 6. Global Cancer Gene Testing Service Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Cancer Gene Testing Service Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Cancer Gene Testing Service Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Cancer Gene Testing Service Market Share by Region (2018-2023)
Table 10. Global Cancer Gene Testing Service Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Cancer Gene Testing Service Market Share by Region (2024-2029)
Table 12. Cancer Gene Testing Service Market Trends
Table 13. Cancer Gene Testing Service Market Drivers
Table 14. Cancer Gene Testing Service Market Challenges
Table 15. Cancer Gene Testing Service Market Restraints
Table 16. Global Cancer Gene Testing Service Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Cancer Gene Testing Service Market Share by Players (2018-2023)
Table 18. Global Top Cancer Gene Testing Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Gene Testing Service as of 2022)
Table 19. Ranking of Global Top Cancer Gene Testing Service Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Cancer Gene Testing Service Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Cancer Gene Testing Service Product Solution and Service
Table 23. Date of Enter into Cancer Gene Testing Service Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cancer Gene Testing Service Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Cancer Gene Testing Service Revenue Market Share by Type (2018-2023)
Table 27. Global Cancer Gene Testing Service Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Cancer Gene Testing Service Revenue Market Share by Type (2024-2029)
Table 29. Global Cancer Gene Testing Service Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Cancer Gene Testing Service Revenue Market Share by Application (2018-2023)
Table 31. Global Cancer Gene Testing Service Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Cancer Gene Testing Service Revenue Market Share by Application (2024-2029)
Table 33. North America Cancer Gene Testing Service Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Cancer Gene Testing Service Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Cancer Gene Testing Service Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Cancer Gene Testing Service Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Cancer Gene Testing Service Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Cancer Gene Testing Service Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Cancer Gene Testing Service Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Cancer Gene Testing Service Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Cancer Gene Testing Service Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Cancer Gene Testing Service Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Cancer Gene Testing Service Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Cancer Gene Testing Service Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Cancer Gene Testing Service Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Cancer Gene Testing Service Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Cancer Gene Testing Service Market Size by Country (2024-2029) & (US$ Million)
Table 48. Natera, Inc. Company Detail
Table 49. Natera, Inc. Business Overview
Table 50. Natera, Inc. Cancer Gene Testing Service Product
Table 51. Natera, Inc. Revenue in Cancer Gene Testing Service Business (2018-2023) & (US$ Million)
Table 52. Natera, Inc. Recent Development
Table 53. Laboratory Corporation of America Holdings Company Detail
Table 54. Laboratory Corporation of America Holdings Business Overview
Table 55. Laboratory Corporation of America Holdings Cancer Gene Testing Service Product
Table 56. Laboratory Corporation of America Holdings Revenue in Cancer Gene Testing Service Business (2018-2023) & (US$ Million)
Table 57. Laboratory Corporation of America Holdings Recent Development
Table 58. F. Hoffmann-La Roche Ltd Company Detail
Table 59. F. Hoffmann-La Roche Ltd Business Overview
Table 60. F. Hoffmann-La Roche Ltd Cancer Gene Testing Service Product
Table 61. F. Hoffmann-La Roche Ltd Revenue in Cancer Gene Testing Service Business (2018-2023) & (US$ Million)
Table 62. F. Hoffmann-La Roche Ltd Recent Development
Table 63. Quest Diagnostics Incorporated Company Detail
Table 64. Quest Diagnostics Incorporated Business Overview
Table 65. Quest Diagnostics Incorporated Cancer Gene Testing Service Product
Table 66. Quest Diagnostics Incorporated Revenue in Cancer Gene Testing Service Business (2018-2023) & (US$ Million)
Table 67. Quest Diagnostics Incorporated Recent Development
Table 68. CooperSurgical, Inc. Company Detail
Table 69. CooperSurgical, Inc. Business Overview
Table 70. CooperSurgical, Inc. Cancer Gene Testing Service Product
Table 71. CooperSurgical, Inc. Revenue in Cancer Gene Testing Service Business (2018-2023) & (US$ Million)
Table 72. CooperSurgical, Inc. Recent Development
Table 73. Agilent Technologies, Inc. Company Detail
Table 74. Agilent Technologies, Inc. Business Overview
Table 75. Agilent Technologies, Inc. Cancer Gene Testing Service Product
Table 76. Agilent Technologies, Inc. Revenue in Cancer Gene Testing Service Business (2018-2023) & (US$ Million)
Table 77. Agilent Technologies, Inc. Recent Development
Table 78. Thermo Fisher Scientific, Inc. Company Detail
Table 79. Thermo Fisher Scientific, Inc. Business Overview
Table 80. Thermo Fisher Scientific, Inc. Cancer Gene Testing Service Product
Table 81. Thermo Fisher Scientific, Inc. Revenue in Cancer Gene Testing Service Business (2018-2023) & (US$ Million)
Table 82. Thermo Fisher Scientific, Inc. Recent Development
Table 83. Twist Bioscience Company Detail
Table 84. Twist Bioscience Business Overview
Table 85. Twist Bioscience Cancer Gene Testing Service Product
Table 86. Twist Bioscience Revenue in Cancer Gene Testing Service Business (2018-2023) & (US$ Million)
Table 87. Twist Bioscience Recent Development
Table 88. Sophia Genetics Company Detail
Table 89. Sophia Genetics Business Overview
Table 90. Sophia Genetics Cancer Gene Testing Service Product
Table 91. Sophia Genetics Revenue in Cancer Gene Testing Service Business (2018-2023) & (US$ Million)
Table 92. Sophia Genetics Recent Development
Table 93. Fulgent Genetic, Inc. Company Detail
Table 94. Fulgent Genetic, Inc. Business Overview
Table 95. Fulgent Genetic, Inc. Cancer Gene Testing Service Product
Table 96. Fulgent Genetic, Inc. Revenue in Cancer Gene Testing Service Business (2018-2023) & (US$ Million)
Table 97. Fulgent Genetic, Inc. Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 1. Global Cancer Gene Testing Service Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Breast Cancer Risk Genetic Testing
Table 3. Key Players of Stomach Cancer Risk Gene Testing
Table 4. Key Players of Rectal Cancer Risk Genetic Testing
Table 5. Key Players of Others
Table 6. Global Cancer Gene Testing Service Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Cancer Gene Testing Service Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Cancer Gene Testing Service Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Cancer Gene Testing Service Market Share by Region (2018-2023)
Table 10. Global Cancer Gene Testing Service Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Cancer Gene Testing Service Market Share by Region (2024-2029)
Table 12. Cancer Gene Testing Service Market Trends
Table 13. Cancer Gene Testing Service Market Drivers
Table 14. Cancer Gene Testing Service Market Challenges
Table 15. Cancer Gene Testing Service Market Restraints
Table 16. Global Cancer Gene Testing Service Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Cancer Gene Testing Service Market Share by Players (2018-2023)
Table 18. Global Top Cancer Gene Testing Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Gene Testing Service as of 2022)
Table 19. Ranking of Global Top Cancer Gene Testing Service Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Cancer Gene Testing Service Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Cancer Gene Testing Service Product Solution and Service
Table 23. Date of Enter into Cancer Gene Testing Service Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cancer Gene Testing Service Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Cancer Gene Testing Service Revenue Market Share by Type (2018-2023)
Table 27. Global Cancer Gene Testing Service Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Cancer Gene Testing Service Revenue Market Share by Type (2024-2029)
Table 29. Global Cancer Gene Testing Service Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Cancer Gene Testing Service Revenue Market Share by Application (2018-2023)
Table 31. Global Cancer Gene Testing Service Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Cancer Gene Testing Service Revenue Market Share by Application (2024-2029)
Table 33. North America Cancer Gene Testing Service Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Cancer Gene Testing Service Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Cancer Gene Testing Service Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Cancer Gene Testing Service Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Cancer Gene Testing Service Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Cancer Gene Testing Service Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Cancer Gene Testing Service Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Cancer Gene Testing Service Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Cancer Gene Testing Service Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Cancer Gene Testing Service Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Cancer Gene Testing Service Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Cancer Gene Testing Service Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Cancer Gene Testing Service Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Cancer Gene Testing Service Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Cancer Gene Testing Service Market Size by Country (2024-2029) & (US$ Million)
Table 48. Natera, Inc. Company Detail
Table 49. Natera, Inc. Business Overview
Table 50. Natera, Inc. Cancer Gene Testing Service Product
Table 51. Natera, Inc. Revenue in Cancer Gene Testing Service Business (2018-2023) & (US$ Million)
Table 52. Natera, Inc. Recent Development
Table 53. Laboratory Corporation of America Holdings Company Detail
Table 54. Laboratory Corporation of America Holdings Business Overview
Table 55. Laboratory Corporation of America Holdings Cancer Gene Testing Service Product
Table 56. Laboratory Corporation of America Holdings Revenue in Cancer Gene Testing Service Business (2018-2023) & (US$ Million)
Table 57. Laboratory Corporation of America Holdings Recent Development
Table 58. F. Hoffmann-La Roche Ltd Company Detail
Table 59. F. Hoffmann-La Roche Ltd Business Overview
Table 60. F. Hoffmann-La Roche Ltd Cancer Gene Testing Service Product
Table 61. F. Hoffmann-La Roche Ltd Revenue in Cancer Gene Testing Service Business (2018-2023) & (US$ Million)
Table 62. F. Hoffmann-La Roche Ltd Recent Development
Table 63. Quest Diagnostics Incorporated Company Detail
Table 64. Quest Diagnostics Incorporated Business Overview
Table 65. Quest Diagnostics Incorporated Cancer Gene Testing Service Product
Table 66. Quest Diagnostics Incorporated Revenue in Cancer Gene Testing Service Business (2018-2023) & (US$ Million)
Table 67. Quest Diagnostics Incorporated Recent Development
Table 68. CooperSurgical, Inc. Company Detail
Table 69. CooperSurgical, Inc. Business Overview
Table 70. CooperSurgical, Inc. Cancer Gene Testing Service Product
Table 71. CooperSurgical, Inc. Revenue in Cancer Gene Testing Service Business (2018-2023) & (US$ Million)
Table 72. CooperSurgical, Inc. Recent Development
Table 73. Agilent Technologies, Inc. Company Detail
Table 74. Agilent Technologies, Inc. Business Overview
Table 75. Agilent Technologies, Inc. Cancer Gene Testing Service Product
Table 76. Agilent Technologies, Inc. Revenue in Cancer Gene Testing Service Business (2018-2023) & (US$ Million)
Table 77. Agilent Technologies, Inc. Recent Development
Table 78. Thermo Fisher Scientific, Inc. Company Detail
Table 79. Thermo Fisher Scientific, Inc. Business Overview
Table 80. Thermo Fisher Scientific, Inc. Cancer Gene Testing Service Product
Table 81. Thermo Fisher Scientific, Inc. Revenue in Cancer Gene Testing Service Business (2018-2023) & (US$ Million)
Table 82. Thermo Fisher Scientific, Inc. Recent Development
Table 83. Twist Bioscience Company Detail
Table 84. Twist Bioscience Business Overview
Table 85. Twist Bioscience Cancer Gene Testing Service Product
Table 86. Twist Bioscience Revenue in Cancer Gene Testing Service Business (2018-2023) & (US$ Million)
Table 87. Twist Bioscience Recent Development
Table 88. Sophia Genetics Company Detail
Table 89. Sophia Genetics Business Overview
Table 90. Sophia Genetics Cancer Gene Testing Service Product
Table 91. Sophia Genetics Revenue in Cancer Gene Testing Service Business (2018-2023) & (US$ Million)
Table 92. Sophia Genetics Recent Development
Table 93. Fulgent Genetic, Inc. Company Detail
Table 94. Fulgent Genetic, Inc. Business Overview
Table 95. Fulgent Genetic, Inc. Cancer Gene Testing Service Product
Table 96. Fulgent Genetic, Inc. Revenue in Cancer Gene Testing Service Business (2018-2023) & (US$ Million)
Table 97. Fulgent Genetic, Inc. Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Cancer Gene Testing Service Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Cancer Gene Testing Service Market Share by Type: 2022 VS 2029
Figure 3. Breast Cancer Risk Genetic Testing Features
Figure 4. Stomach Cancer Risk Gene Testing Features
Figure 5. Rectal Cancer Risk Genetic Testing Features
Figure 6. Others Features
Figure 7. Global Cancer Gene Testing Service Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Cancer Gene Testing Service Market Share by Application: 2022 VS 2029
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Cancer Gene Testing Service Report Years Considered
Figure 12. Global Cancer Gene Testing Service Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Cancer Gene Testing Service Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Cancer Gene Testing Service Market Share by Region: 2022 VS 2029
Figure 15. Global Cancer Gene Testing Service Market Share by Players in 2022
Figure 16. Global Top Cancer Gene Testing Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Gene Testing Service as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Cancer Gene Testing Service Revenue in 2022
Figure 18. North America Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Cancer Gene Testing Service Market Share by Country (2018-2029)
Figure 20. United States Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Cancer Gene Testing Service Market Share by Country (2018-2029)
Figure 24. Germany Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Cancer Gene Testing Service Market Share by Region (2018-2029)
Figure 32. China Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Cancer Gene Testing Service Market Share by Country (2018-2029)
Figure 40. Mexico Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Cancer Gene Testing Service Market Share by Country (2018-2029)
Figure 44. Turkey Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Natera, Inc. Revenue Growth Rate in Cancer Gene Testing Service Business (2018-2023)
Figure 47. Laboratory Corporation of America Holdings Revenue Growth Rate in Cancer Gene Testing Service Business (2018-2023)
Figure 48. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Cancer Gene Testing Service Business (2018-2023)
Figure 49. Quest Diagnostics Incorporated Revenue Growth Rate in Cancer Gene Testing Service Business (2018-2023)
Figure 50. CooperSurgical, Inc. Revenue Growth Rate in Cancer Gene Testing Service Business (2018-2023)
Figure 51. Agilent Technologies, Inc. Revenue Growth Rate in Cancer Gene Testing Service Business (2018-2023)
Figure 52. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Cancer Gene Testing Service Business (2018-2023)
Figure 53. Twist Bioscience Revenue Growth Rate in Cancer Gene Testing Service Business (2018-2023)
Figure 54. Sophia Genetics Revenue Growth Rate in Cancer Gene Testing Service Business (2018-2023)
Figure 55. Fulgent Genetic, Inc. Revenue Growth Rate in Cancer Gene Testing Service Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Figure 1. Global Cancer Gene Testing Service Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Cancer Gene Testing Service Market Share by Type: 2022 VS 2029
Figure 3. Breast Cancer Risk Genetic Testing Features
Figure 4. Stomach Cancer Risk Gene Testing Features
Figure 5. Rectal Cancer Risk Genetic Testing Features
Figure 6. Others Features
Figure 7. Global Cancer Gene Testing Service Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Cancer Gene Testing Service Market Share by Application: 2022 VS 2029
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Cancer Gene Testing Service Report Years Considered
Figure 12. Global Cancer Gene Testing Service Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Cancer Gene Testing Service Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Cancer Gene Testing Service Market Share by Region: 2022 VS 2029
Figure 15. Global Cancer Gene Testing Service Market Share by Players in 2022
Figure 16. Global Top Cancer Gene Testing Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Gene Testing Service as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Cancer Gene Testing Service Revenue in 2022
Figure 18. North America Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Cancer Gene Testing Service Market Share by Country (2018-2029)
Figure 20. United States Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Cancer Gene Testing Service Market Share by Country (2018-2029)
Figure 24. Germany Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Cancer Gene Testing Service Market Share by Region (2018-2029)
Figure 32. China Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Cancer Gene Testing Service Market Share by Country (2018-2029)
Figure 40. Mexico Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Cancer Gene Testing Service Market Share by Country (2018-2029)
Figure 44. Turkey Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Cancer Gene Testing Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Natera, Inc. Revenue Growth Rate in Cancer Gene Testing Service Business (2018-2023)
Figure 47. Laboratory Corporation of America Holdings Revenue Growth Rate in Cancer Gene Testing Service Business (2018-2023)
Figure 48. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Cancer Gene Testing Service Business (2018-2023)
Figure 49. Quest Diagnostics Incorporated Revenue Growth Rate in Cancer Gene Testing Service Business (2018-2023)
Figure 50. CooperSurgical, Inc. Revenue Growth Rate in Cancer Gene Testing Service Business (2018-2023)
Figure 51. Agilent Technologies, Inc. Revenue Growth Rate in Cancer Gene Testing Service Business (2018-2023)
Figure 52. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Cancer Gene Testing Service Business (2018-2023)
Figure 53. Twist Bioscience Revenue Growth Rate in Cancer Gene Testing Service Business (2018-2023)
Figure 54. Sophia Genetics Revenue Growth Rate in Cancer Gene Testing Service Business (2018-2023)
Figure 55. Fulgent Genetic, Inc. Revenue Growth Rate in Cancer Gene Testing Service Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
